Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2019-08-15 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
2019年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 年半年度报告全文" which translates to "2019 Semi-Annual Report Full Text." It contains detailed financial data, management discussion and analysis, business overview, financial indicators, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. It includes actual financial statements, analysis of business segments, and detailed financial metrics for the half-year period ending in 2019. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-15 Chinese
关于公司全资子公司获得《药品GMP证书》的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (673 characters) about the company's wholly-owned subsidiary receiving a GMP certificate from a regulatory authority. It does not contain financial statements, detailed financial data, or management discussion. It is an official announcement regarding a regulatory certification related to product quality and compliance. The document is not a full report, earnings release, or management report. It fits best as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit other specific categories.
2019-08-07 Chinese
关于全资子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 普洛药业股份有限公司 regarding government subsidies received by its wholly-owned subsidiaries. It details the amounts, sources, and accounting treatment of these subsidies and their expected positive impact on the company's 2019 third quarter net profit. The document is relatively short (2134 characters) and serves as an announcement of financial impact rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed management analysis. It is not a certification or officer attestation. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for filings that do not fit other specific categories.
2019-07-30 Chinese
2019年半年度业绩快报
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2019年半年度业绩快报' which translates to '2019 Half-Year Performance Express Report'. It contains preliminary financial data for the half-year period, including revenue, profit, net income, and other financial metrics. The document explicitly states that the data is preliminary and unaudited, and it is a summary of half-year financial performance. This matches the characteristics of an Interim / Quarterly Report (IR), which provides comprehensive financial data for a period shorter than a full fiscal year. The document length is short but contains substantive financial data and analysis, not just an announcement or certification. Therefore, it should be classified as an Interim / Quarterly Report (IR). H1 2019
2019-07-29 Chinese
关于公司全资子公司以自有闲置资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 普洛药业股份有限公司 regarding the purchase of financial products (理财产品) by its wholly-owned subsidiary using idle funds. It details the product name, type, investment amount, risk analysis, and control measures. The document includes references to board resolutions and shareholder meeting approvals but does not contain financial statements or comprehensive financial performance data. The length is 1774 characters, which is relatively short and the content is focused on a specific financing activity rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities related to investment of idle funds in financial products.
2019-07-17 Chinese
关于会计师事务所更名的公告
Audit Report / Information Classification · 90% confidence The document is a short announcement regarding the name change of the company's auditing firm. It explicitly states that the accounting firm has changed its name but that there is no change in qualifications or a reappointment of the auditor. The document is only 552 characters long and does not contain any financial data, audit results, or detailed audit information. It is an announcement related to audit firm information but not a full audit report. Therefore, it fits best under 'Audit Report / Information' (AR) as it pertains to audit-related information but is not a full audit report or annual report. Confidence is high given the clear content and length. FY 2019
2019-07-09 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.